1,929 results on '"Ben-David, Yaacov"'
Search Results
2. FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression
3. Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2
4. Targeting pivotal amino acids metabolism for treatment of leukemia
5. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway
6. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
7. CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
8. Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
9. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer
10. Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS/HDAC1/EP300/PEBP1 axis
11. A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux
12. The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.
13. FLI1 regulates inflammation-associated genes to accelerate leukemogenesis
14. FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes
15. UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
16. An Overview of Heavy Metal Toxicity
17. Ubash3b promotes TPA-mediated suppression of leukemogenesis through accelerated downregulation of PKCδ protein
18. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues
19. Light-Activated Nanoparticles for Antibacterial Studies
20. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
21. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway
22. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells
23. Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
24. ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes
25. BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells
26. The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
27. B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis.
28. Synthesis of novel guttiferone E and xanthochymol derivatives with cytotoxicities by inducing cell apoptosis and arresting the cell cycle phase
29. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer
30. Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
31. Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity
32. Erythropoietin
33. Thinking (Metastasis) outside the (Primary Tumor) Box
34. A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3
35. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
36. Gut microbiota and brain development: A review
37. Synthesis of Metal Nanoparticles from Fungi: A Biosynthesis Approach
38. Delivery of Peptides, Peptones and Proteins for Specific Intracellular Trafficking through Targeted Nanoparticles: Nanoparticle-assisted Cancer Drug Delivery Regimes
39. Light-Activated Nanoparticles for Antibacterial Studies
40. Erythropoietin
41. Molecular stratification within triple-negative breast cancer subtypes
42. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity
43. FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
44. Supplementary Figures 1 - 8, Tables 1 - 2 from mda-7/IL-24 Expression Inhibits Breast Cancer through Upregulation of Growth Arrest-Specific Gene 3 (gas3) and Disruption of β1 Integrin Function
45. Supplementary Figure S1 from Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy
46. Data from Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy
47. Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
48. Additional file 1 of Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
49. Additional file 2 of Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
50. Additional file 3 of Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.